Abstract:Background: Diabetes, a globally escalating health concern, necessitates innovative solutions for efficient detection and management. Blood glucose control is an essential aspect of managing diabetes and finding the most effective ways to control it. The latest findings suggest that a basal insulin administration rate and a single, high-concentration injection before a meal may not be sufficient to maintain healthy blood glucose levels. While the basal insulin rate treatment can stabilize blood glucose levels over the long term, it may not be enough to bring the levels below the post-meal limit after 60 min. The short-term impacts of meals can be greatly reduced by high-concentration injections, which can help stabilize blood glucose levels. Unfortunately, they cannot provide long-term stability to satisfy the post-meal or pre-meal restrictions. However, proportional-integral-derivative (PID) control with basal dose maintains the blood glucose levels within the range for a longer period. Aim: To develop a closed-loop electronic system to pump required insulin into the patient's body automatically in synchronization with glucose sensor readings. Methods: The proposed system integrates a glucose sensor, decision unit, and pumping module to specifically address the pumping of insulin and enhance system effectiveness. Serving as the intelligence hub, the decision unit analyzes data from the glucose sensor to determine the optimal insulin dosage, guided by a pre-existing glucose and insulin level table. The artificial intelligence detection block processes this information, providing decision instructions to the pumping module. Equipped with communication antennas, the glucose sensor and micropump operate in a feedback loop, creating a closed-loop system that eliminates the need for manual intervention. Results: The incorporation of a PID controller to assess and regulate blood glucose and insulin levels in individuals with diabetes introduces a sophisticated and dynamic element to diabetes management. The simulation not only allows visualization of how the body responds to different inputs but also offers a valuable tool for predicting and testing the effects of various interventions over time. The PID controller's role in adjusting insulin dosage based on the discrepancy between desired setpoints and actual measurements showcases a proactive strategy for maintaining blood glucose levels within a healthy range. This dynamic feedback loop not only delays the onset of steady-state conditions but also effectively counteracts post-meal spikes in blood glucose. Conclusion: The WiFi-controlled voltage controller and the PID controller simulation collectively underscore the ongoing efforts to enhance efficiency, safety, and personalized care within the realm of diabetes management. These technological advancements not only contribute to the optimization of insulin delivery systems but also have the potential to reshape our understanding of glucose and insulin dynamics, fostering a new era of precision medicine in the treatment of diabetes.

Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Dual Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine

Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1.

A novel pulse-modulated closed-loop artificial pancreas based on intravenous administration of insulin and glucagon

Basal Glucose Control in Type 1 Diabetes Using Deep Reinforcement Learning: An In Silico Validation

Continuous Drug Infusion for Diabetes Therapy: A Closed-Loop Control System Design

Blood glucose regulation and control of insulin and glucagon infusion using single model predictive control for type 1 diabetes mellitus

Gaussian Process-Based Model Predictive Control of Blood Glucose for Patients with Type 1 Diabetes Mellitus

Design of reduced multiple model predictive controller for glucose–insulin regulation in type 1 diabetic patients

The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control

Blood glucose regulation in type 1 diabetic patients: an adaptive parametric compensation control‐based approach

Artificial intelligence powered glucose monitoring and controlling system: Pumping module

PID Control of Glucose Concentration in Subjects with Type 1 Diabetes Based on a Simplified Model: an in Silico Trial

Intermittent Control for Safe Long-Acting Insulin Intensification for Type 2 Diabetes: In-Silico Experiment

Glucose-Responsive Synthetic Closed-Loop Insulin Delivery Systems

Design and Validation of an Open-Source Closed-Loop Testbed for Artificial Pancreas Systems

Linear Quadratic Gaussian-Based Closed-Loop Control of Type 1 Diabetes

Closed-loop insulin delivery: current status of diabetes technologies and future prospects

Glucose‐Responsive Insulin and Delivery Systems: Innovation and Translation

A comprehensive review of models and nonlinear control strategies for blood glucose regulation in artificial pancreas

Glucose-activated switch regulating insulin analogue secretion enables long-term precise glucose control in type 1 diabetes mice

Evaluating Deep Q-Learning Algorithms for Controlling Blood Glucose in In Silico Type 1 Diabetes